Gastrointestinal stromal tumor | Tumor

FDA Approves Qinlock for Patients with Pretreated, Advanced GIST

May 16th 2020, 1:26am

The targeted drug Qinlock, which interferes with the activity of proteins that drive gastrointestinal stromal tumor, has been approved by the Food and Drug Administration for patients with advanced disease that has progressed despite treatment with other kinase inhibitors.

What You Need to Know About the FDA's Approval of Avyakit for GIST Subgroup

January 13th 2020, 9:17pm

Patients with gastrointestinal stromal tumors have a new targeted therapy that looks to tackle secondary mutations after it showed a strong response rate in the clinic.

FDA Approves Ayvakit for the Treatment of Certain Patients with Gastrointestinal Stromal Tumor

January 10th 2020, 3:29am

The Food and Drug Administration approved Ayvakit for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumor who exhibited a platelet-derived growth factor receptor alpha exon 18 mutation.

Hitting a Target in Gastrointestinal Stromal Tumors

August 2nd 2017, 8:23pm

How zeroing in on the mutation in gastrointestinal stromal tumors is adding years to patients’ lives

Collaboration Lays the Groundwork for Breakthroughs in GIST

January 29th 2017, 10:33pm

The Life Raft Group, a patient advocacy organization, is teaming up with research organizations to hopefully find the next wave of treatment for patients with gastrointestinal stromal tumors.

Gastrointestinal Stromal Tumors Already Proving to Be Treatable With Targeted Therapies

March 23rd 2016, 11:39pm

Identified only a decade-and-a-half ago, GIST is already treatable with several targeted therapies, and scientists are researching more.

Side Effects Associated With Other Treatments for GIST

October 22nd 2015, 1:15am

Side Effects Associated With Gleevec for GIST

October 22nd 2015, 1:15am

Treating GIST

October 22nd 2015, 1:15am

What Is GIST?

October 22nd 2015, 1:15am